1055073-69-2

Basic information

• Product Name: 2-(2-BroMo-pyridin-4-yl)-propan-2-ol
• Synonyms: 2-(2-BroMo-pyridin-4-yl)-propan-2-ol
• CAS NO: 1055073-69-2
• Molecular Formula: C₈H₁₀BrNO
• Molecular Weight: 216.0751
• Mol File: 1055073-69-2.mol

Chemical Properties

• Boiling Point: 297.9±25.0 °C(Predicted)
• Appearance: /
• Density: 1.474±0.06 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 13.20±0.29(Predicted)
• CAS DataBase Reference: 2-(2-BroMo-pyridin-4-yl)-propan-2-ol(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(2-BroMo-pyridin-4-yl)-propan-2-ol(1055073-69-2)
• EPA Substance Registry System: 2-(2-BroMo-pyridin-4-yl)-propan-2-ol(1055073-69-2)

Safety Data

• Hazardous Substances Data: 1055073-69-2(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Research:
2-(2-Bromo-pyridin-4-yl)-propan-2-ol is used as a reagent and building block for the synthesis of various pharmaceutical drugs. Its unique chemical structure allows it to be a valuable component in the development of new medications.
Used in Chemical Research:
In the field of chemical research, 2-(2-Bromo-pyridin-4-yl)-propan-2-ol is utilized as an intermediate in the production of other organic compounds. Its role in these processes is essential for creating a range of chemical products.
Used in Laboratory Settings:
2-(2-BroMo-pyridin-4-yl)-propan-2-ol is mainly used in laboratory settings for research and development purposes. Its application in these controlled environments helps to ensure safety and proper handling during experimentation and synthesis processes.

Upstream product

• 26156-48-9 methyl 2-bromoisonicotinate 
• 656257-69-1 2-bromo-N-methyl-N-(methyloxy)-4-pyridinecarboxamide 
• 66572-56-3 2-bromoisonicotinic acid 
• 75-16-1 methylmagnesium bromide 
• 111043-06-2 1-(2-bromo-4-pyridinyl)ethanone 

Relevant articles and documents

Aminopyridyloxypyrazole derivative and preparation method and application thereof

The invention relates to an aminopyridyloxypyrazole derivative and a preparation method and application thereof. The structure of the aminopyridyloxypyrazole derivative is shown as a formula (I). The invention provides a brand-new aminopyridyloxypyrazole derivative which has obvious effects of inhibiting TGF [beta] R1 (ALK5) kinase activity and treating cancer or fibrosis related diseases, and the preparation method of the derivative is simple and easy to operate.

Antibacterial Compounds

The present invention provides a compound of the following formula, salts, racemates, diastereomers, enantiomers, esters, carbamates, phosphates, sulfates, deuterated forms and prodrugs thereof. Also provided is the use of these compounds as antibacterials, compositions comprising them and processes for their manufacture.

POLYSUBSTITUTED DERIVATIVES OF 6-HETEROARYLIMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF

Compounds of formula (I): wherein R1, R2, R3, R4, Het and X are as defined in the disclosure, or an acid addition salt thereof, and the therapeutic use and process of synthesis thereof.

METHOD OF PREPARING INHIBITORS OF PHOSPHODIESTERASE-4

In one aspect, the present invention is directed to a one pot method of preparing intermediates of Formula V, which are useful in making inhibitors of phosphodiesterase-4: The present invention is also directed to a method of preparing phosphodiesterase inhibitors comprising the Formula

1-biaryl-1,8-naphthyridin-4-one phosphodiesterase-4 inhibitors

Compounds represented by Formula (I): or a pharmaceutically acceptable salt thereof, are phosphodiesterrase 4 inhibitors useful in the treatment of asthma and inflammation.